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The utility of a rapid latex slide agglutination test (Campyslide; BBL Microbiology Systems, Cockeysville,
Md.) in detecting selected Campylobacter spp. was evaluated and compared with that of conventional
identification methods. Isolated colonies suggestive of Campylobacter spp. were tested directly from primary
selective media after incubationj at 42°C under microaerophilic conditions. Stock cultures of Campylobacter
jejuni (n = 27) and C. coli (n = 3) were correctly confirmed to the genus level by latex agglutination when tested
in pure cultures or isolated from seeded human feces. A total of 50 fresh clinical isolates of Campylobacter spp.
(45 C. jejuni and 5 C. colt) were examined, with complete agreement observed between the latex test and
conventional methods. Of 173 non-Campylobacter isolates tested from primary plates, only 1 rough strain of
Pseudomonas aeruginosa produced a false-positive result. Although the manufacturer recommends a 30-min
antigen extraction, 1 or 5 min was found to be sufficient. Also, confirmation could be achieved within 24 h of
inoculation of clinical specimens, 2 days earlier than with conventional methods.
In recent years, Campylobacter spp., particularly Cam-
pylobacterjejuni, have been recognized as important human
pathogens which cause both acute bacterial gastroenteritis
and extraintestinal infections (1-5, 7, 8, 10, 13). The inci-
dence of Campylobacter infections in the United States has
been estimated at 1 to 2 million cases per year (3). C. jejuni
has been isolated from 3 to 14% of patients with diarrheal
illness in Europe and North America (2, 3, 5) and has been
found in every country in which surveillance has been
reported (2-4, 6, 8). Isolation rates for this organism have
approached and often surpassed those of Salmonella spp. or
Shigella spp. in patients with enteric illness (4, 6, 12, 14).
Individuals of all ages have been infected with C. jejuni,
although infections are most frequent in young children and
young adults (2, 3, 5, 9). Campylobacter infections are
especially prevalent among college students, with the frac-
tion of stool cultures yielding Campylobacter spp. on U.S.
college campuses ranging from 13 to 53% (14).
Early resolution of the clinical symptoms of acute gas-
troenteritis and clearance of the organism from stools are
dependent upon promptly beginning appropriate antibiotic
therapy (1). To do this, rapid determination of the presence
of Campylobacter spp. in feces is required. Currently, the
definitive identification of Campylobacter spp. by conven-
tional isolation and biochemical techniques requires a mini-
mum of 48 to 72 h. Presumptive identification of these
organisms based on Gram staining and oxidase testing re-
quires only 24 to 48 h to accomplish, but the accuracy of this
identification is dependent on the proficiency of the technol-
ogist. In many laboratories in which the isolation of Cam-
pylobacter spp. is uncommon, the accuracy of this presump-
tive identification may not be acceptable. We have evaluated
the utility of the Campyslide (BBL Microbiology Systems,
Cockeysville, Md.) latex agglutination (LA) test in detecting
cell wall antigens of selected Campylobacter spp. This test
provides a rapid and simple genus-level confirmation of
these human pathogens from cultures.
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MATERIALS AND METHODS
Bacterial isolates. All bacterial strains studied were clinical
isolates recovered at North Carolina Memorial Hospital
(NCMH) or the Student Health Service (SHS) of the Uni-
versity of North Carolina, Chapel Hill. The organisms were
either fresh clinical isolates or isolates which were recovered
from stool specimens from patients and stored frozen in
horse blood at -70°C until used. A total of 253 fresh clinical
isolates and stock cultures, including 80 Campylobacter spp.
and 173 non-Campylobacter isolates, were tested by LA. All
Campylobacter isolates were positively identified to the
species level by the methods described by Morris and Patton
(11). Non-Campylobacter isolates were identified to the
species level by Gram staining, catalase and oxidase reac-
tions, and conventional biochemical and physiological meth-
ods.
Culture conditions. Fresh stool specimens from patients
and stock culture isolates of Campylobacter spp. were
inoculated onto campylobacter agar or campylobacter CVA
agar (BBL). Incubation was for 24 or 48 h at 42°C under a
microaerophilic atmosphere provided by the CampyPak
Envelope (BBL) and jar system or the Campy Pouch (BBL)
system. All Campylobacter and non-Campylobacter orga-
nisms were isolated from the same media and under the same
incubation conditions. For experiments involving seeded
stools, six human diarrheal stool specimens, confirmed to be
negative fôr Campylobacter spp., were pooled, and 0.9-ml
aliquots were inoculated with 0.1 ml of a turbid suspension
(McFarland no. 2 standard) of each stock culture isolate of
Campylobacter spp. The seeded stools were inoculated onto
campylobacter CVA agar by using sterile Dacron-tipped
swabs and were incubated for 24 or 48 h as described above.
Campyslide LA test. The Campyslide test is an LA assay
for the confirmatory genus-level identification of the four
major Campylobacter pathogens of human illness (C. jejuni,
C. coli, C. laridis, and C. fetus subsp. fetus) from cultures.
The test is based upon the detection of cell wall antigens
found in these species by use of an anti-Campylobacter
antibody-coated latex bead suspension. Initially, the
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Campyslide test was assessed with stock strains of Campylo-
bacter spp. in pure cultures or isolated from seeded human
feces. The performance of the test was subsequently evalu-
ated with fresh clinical specimens. Both Campylobacter spp.
and non-Campylobacter spp. were tested directly from pri-
mary plates of Campylobacter selective media. A limited
amount of the organism, either as isolated colonies or as
confluent growth from these plates, was required to perform
the LA test. The LA test was performed in accordance with
the instructions of the manufacture with minor modifica-
tions. Briefly, bacterial isolates were suspended in 0.2 ml of
extraction reagent to achieve a slightly turbid suspension
(McFarland no. 0.5 to 1 standard) and were extracted for 1,
5, or 30 min at room temperature. This step was followed by
the addition of 0.2 ml of neutralization reagent. The suspen-
sion was vortexed thoroughly, and a change in color from
yellow to a mid- to deep purple was indicative of neutrali-
zation. If the suspension remained yellow, at least 1 addi-
tional drop (5 to 20 ,ul) of neutralization reagent was added to
neutralize the mixture. The neutralized antigen extracts (25
,ul) were placed onto two circles of a test slide, and 1 drop (25
,ul) each of reactive latex and control latex was dispensed for
each organism tested. The extract and latex were mixed with
plastic stirrers, and the test slide was rotated at 100 rpm on
a mechanical rotator for 3 to 4 min. The test slide was then
read for distinct visible agglutination. If a sample produced
weak agglutination, the test slide was rotated for an addi-
tional 6 min before being read again. A positive antigen
control and a negative reagent control were tested with each
set of specimens. Agglutination was scored as positive,
equivocal, or negative. Equivocal results were considered
negative.
RESULTS AND DISCUSSION
Initial studies with stock cultures of 27 strains of C. jejuni
and 3 strains of C. coli were positive by LA when tested in
pure cultures or after isolation from seeded human feces
(Table 1). Studies on fresh clinical specimens were then
performed. The prevalence of Campylobacter spp. between
28 October 1986 and 30 April 1987 was 17.9% (37 of 207) for
SHS, and that for NCMH was 1.6% (14 of 881). A total of 34
(92%) C. jejuni and 3 (8%) C. coli strains were isolated from
SHS, while 12 (86%) C. jejuni and 2 (14%) C. coli strains
were found at NCMH. Of 51 clinical isolates, 50 were
correctly confirmed to the genus level by the LA test (Table
1). One Campylobacter strain isolated from NCMH was not
tested.
Of 173 non-Campylobacter isolates tested from primary
plates, only 1 rough strain of Pseudomonas aeruginosa
TABLE 1. Campyslide test results for stock culture strains and
fresh clinical isolates of Campylobacter spp.
No. of positive organisms
Organism(s)
C. jejuni C. coli
Stock strains (pure cultures) 27 3
Stock strain in seeded fecesb 16 3
(24-h incubation)
Stock strain in seeded feces 27 3
(48-h incubation)
Fresh clinical isolates 45 5
a All tested organisms were positive.
b Some stock strains showed no visible growth in seeded feces after
incubation for 24 h. Growth subsequently occurred after an additional 24 h of
incubation.
repeatedly produced a positive agglutination result. How-
ever, atypical agglutination reactions with either the reactive
or control latex or both were observed for eight other
isolates of this organism. Reactions of this type were rapid,
were atypical in appearance, and occurred while the antigen
extracts were being stirred with the antibody-coated latex
particles. These reactions could not be consistently repro-
duced upon repeat testing of the isolated organisms and were
considered equivocal results. Table 2 summarizes the results
for the non-Campylobacter isolates tested by LA.
Although the manufacturer recommends a 30-min antigen
extraction for the LA test, we found 1 or 5 min to be
sufficient. Antigens extracted for different times from 44
fresh clinical isolates of Campylobacter spp. (24 isolates for
5- and 30-min extraction comparisons; 20 isolates for 1- and
5-min extraction comparisons) performed equally well when
tested by LA (Table 3). A total of 83 non-Campylobacter
isolates were extracted for 5 and 30 min; 79 isolates showed
negative results at both extraction times, and 4 isolates of P.
aeruginosa showed atypical agglutination. Three separate
test kits were used for this comparison, and 11 of the 83
non-Campylobacter isolates were P. aeruginosa. A compar-
ison of 1- and 5-min extraction times revealed negative
results for 49 non-Campylobacter isolates and atypical ag-
glutination for 4 isolates of P. aeruginosa. Four separate kits
were used for this comparison, and 10 of the 53 organisms
examined were P. aeruginosa.
Four medical technologists in the bacteriology laboratory
at NCMH were asked to independently evaluate the Cam-
pyslide test and comment on its performance. In a blind
study, they were given five strains of C. jejuni and five
non-Campylobacter isolates (Escherichia coli, Enterobacter
cloacae, Klebsiella pneumoniae, Citrobacter freundii, ànd
P. aeruginosa) to test by LA. Extraction times of 1 and 5 min
(two technologists for each) were used. All individuals
successfully and correctly completed their evaluations.
Weakly positive agglutination reactions were observed by
one technologist for the C. jejuni isolates after the initial 3- to
4-min rotation of the test slide. In accordance with the
instructions of the manufacturer, the test slide was rotated
for an additional 6 min before being read again. Strong
positive reactions were observed at this time. The P. aeru-
ginosa isolate showed various degrees of atypical agglutina-




Acinetobacter calcoaceticus subsp. anitratus ............. 0/4
Bacteroides fragilis .......................................... 0/1
Citrobacter freundii .......................................... 0/4
Enterobacter cloacae .......................................... 0/21
Enterobacter aerogenes .......................................... 0/7
Enterobacter agglomerans ...................................... 0/1
Escherichia coli.......................................... 0/71
Klebsiella pneumoniae .......................................... 0/10
Klebsiella oxytoca .......................................... 0/5
Lactobacillus spp ................................................. 0/5
Proteus mirabilis ............................. ............. 0/5
Pseudomonas aeruginosa ....................................... 1/27a
Staphylococcus spp. (coagulase negative) .................. 0/4
Yeasts ......................................... 0/7
Yersinia enterocolitica .......................................... 0/1
a One rough strain of P. aeruginosa produced a positive agglutination
result. Atypical agglutination reactions were observed for eight other isolates
of this organism.
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TABLE 3. Detection of Campylobacter isolates by LA following
different antigen extraction times
No. of positive organismsa
Extraction time (min)




a Ail tested organisms were positive.
b Eleven isolates of C. jejuni were tested by LA following 30 min of antigen
extraction only.
C Two isolates of C. coli were tested by LA following 30 min of antigen
extraction only.
tion with the latex test for all of the technologists. The
procedure was well received with the exception of the
neutralization step. More often than not, the technologists
had to add more than an equal volume of neutralization
reagent to neutralize the extraction mixture.
All Campylobacter isolates from SHS were confirmed
within 24 h of inoculation of clinical specimens onto selec-
tive media, 2 days earlier than with conventional methods
routinely used in the bacteriology laboratory at NCMH.
Stools from SHS were processed in batches on a given day,
immediately placed under strict microaerophilic conditions
(CampyPak Envelope or Campy Pouch), and incubated
undisturbed for 18 to 24 h at 42°C. This procedure was not
feasible for the bacteriology laboratory at NCMH, since
processing of all specimens is offered on a 24-h basis.
Therefore, Campylobacter plates were routinely placed in a
candle jar as the stools were processed until they could be
transferred to jars with CampyPak Envelopes by day-shift
personnel. This procedure may have resulted in a delay of
growth of the Campylobacter isolates by an additional 24 h
and, therefore, a subsequent delay in identification. Under
these conditions, the Campyslide test would save only 1 day
in confirming a positive result for Campylobacter spp. in a
clinical specimen.
In conclusion, the Campyslide LA test provides a sensi-
tive and specific test for the confirmatory serological identi-
fication of Campylobacter spp. from primary selective me-
dia. The test is rapid and simple to perform and, with the
exception of an atypical agglutination reaction with some
isolates of P. aeruginosa, the results are distinct and easily
interpreted. The antigen extraction time can be decreased to
i br 5 min, making the test more suitable for a busy clinical
microbiology laboratory. Isolated colonies or confluent
growth suggestive of Campylobacter spp. can be tested as
early as 18 to 24 h after incubation of the primary plates,
making early detection and prompt administration of antibi-
otics feasible.
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